Publications by authors named "Jennifer Fusco"

Claim this Profile
C
Comparable real-world effectiveness between switches to cabotegravir + rilpivirine long-acting or modern daily oral regimens in the United States: an OPERA cohort study.
Ricky K Hsu, Michael G Sension, Jennifer S Fusco, Laurence Brunet, Quateka Cochran, Gregory P Fusco

J Int AIDS Soc· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressed switch to Bictegravir/emtricitabine/tenofovir alafenamide compared with dolutegravir/lamivudine: Real-world evidence from the OPERA cohort.
Gerald Pierone, Laurence Brunet, Jennifer S Fusco, Michael G Sension, Megan S Dunbar, Gregory P Fusco

HIV Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir interruption among people with HIV and HBV: HBV monitoring and risk of HBV reactivation and hepatitis flare.
Douglas T Dieterich, Laurence Brunet, Ricky K Hsu, Karam Mounzer, Gerald Pierone, Jennifer S Fusco, Gregory P Fusco

AIDS· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamide.
Karam Mounzer, Michael D Osterman, Laurence Brunet, Ricky K Hsu, Gerald Pierone, Jennifer S Fusco, Gregory P Fusco

AIDS Res Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight loss with real-world doravirine use in the OPERA cohort: a US-based cohort study.
Karam Mounzer, Laurence Brunet, Michael Sension, Ricky K Hsu, Michael D Osterman, Jennifer S Fusco, Gregory P Fusco

AIDS Res Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study.
Ricky K Hsu, Laurence Brunet, Philip C Lackey, Gerald Pierone, Brooke Levis, Jennifer S Fusco, Gregory P Fusco

HIV Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States.
Gerald Pierone, Jennifer S Fusco, Laurence Brunet, Vani Vannappagari, Supriya Sarkar, Gregory P Fusco

AIDS Res Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incident HIV-Associated Wasting/Low Weight Is Associated with Nearly Doubled Mortality Risk in the Modern ART Era.
Michael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, Javeed Siddiqui, Michael Harbour, Jennifer S Fusco, Gregory P Fusco

AIDS Res Hum Retroviruses· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Adherence to the Target Window for Cabotegravir + Rilpivirine Long-Acting Injections Through the CHORUS™ App and Web Portal: A Cluster Randomized Trial.
Michael B Wohlfeiler, Laurence Brunet, Quateka Cochran, Jennifer S Fusco, Ricky K Hsu, Gregory P Fusco

J Int Assoc Provid AIDS Care· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colonizing the Unlikely: in an Immunocompetent Patient.
Jasmine Tidwell, Jennifer Fusco, Minh Thu T Nguyen, Ga Hie Nam, Steven Goldenberg

ACG Case Rep J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care.
Gerald Pierone, Laurence Brunet, Jennifer S Fusco, Cassidy E Henegar, Supriya Sarkar, Gregory P Fusco

HIV AIDS (Auckl)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA Cohort.
Michael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, Javeed Siddiqui, Michael Harbour, Jennifer S Fusco, Gregory P Fusco

AIDS Res Hum Retroviruses· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort.
Michael G Sension, Laurence Brunet, Ricky K Hsu, Jennifer S Fusco, Quateka Cochran, Gregory P Fusco

Infect Dis Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response to ART initiation in advanced HIV infection.
Karam Mounzer, Laurence Brunet, Jennifer S Fusco, Ian R McNicholl, Megan Dunbar, Gregory P Fusco

HIV Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antioxidant and Anti-Inflammatory Properties of Walnut Constituents: Focus on Personalized Cancer Prevention and the Microbiome.
Nuoxi Fan, Jennifer L Fusco, Daniel W Rosenberg

Antioxidants (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes.
Ricky K Hsu, Jennifer S Fusco, Cassidy E Henegar, Vani Vannappagari, Andrew Clark, Gregory P Fusco

BMC Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV retention in care: results and lessons learned from the Positive Pathways Implementation Trial.
Michael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, Jennifer S Fusco, Christine Uranaka, Gregory P Fusco

BMC Prim Care· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excessive Weight Gain: Current Antiretroviral Agents in Virologically Suppressed People with HIV.
Ricky K Hsu, Laurence Brunet, Jennifer S Fusco, Karam Mounzer, Joyce C Lamori, Gregory P Fusco

AIDS Res Hum Retroviruses· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens.
Karam Mounzer, Laurence Brunet, Jennifer S Fusco, Ian R Mcnicholl, Helena Diaz Cuervo, Gregory P Fusco

Open Forum Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid Changes After Switch From TDF to TAF in the OPERA Cohort: LDL Cholesterol and Triglycerides.
Patrick W G Mallon, Laurence Brunet, Jennifer S Fusco, Girish Prajapati, Andrew Beyer, Gregory P Fusco

Open Forum Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Body Mass Index Associated with Antiretroviral Regimen Switch Among Treatment-Experienced, Virologically Suppressed People Living with HIV in the United States.
Karam Mounzer, Laurence Brunet, Ricky Hsu, Jennifer Fusco, Vani Vannappagari, Gregory Fusco

AIDS Res Hum Retroviruses· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization.
Laurence Brunet, Patrick Mallon, Jennifer S Fusco, Michael B Wohlfeiler, Girish Prajapati, Gregory P Fusco

Clin Drug Investig· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA Cohort.
Karam C Mounzer, Jennifer S Fusco, Ricky K Hsu, Laurence Brunet, Vani Vannappagari, Gregory P Fusco

AIDS Patient Care STDS· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents.
Anthony M Mills, Kathy L Schulman, Jennifer S Fusco, Michael B Wohlfeiler, Julie L Priest, Gregory P Fusco

Open Forum Infect Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight gain before and after switch from TDF to TAF in a U.S. cohort study.
Patrick Wg Mallon, Laurence Brunet, Ricky K Hsu, Jennifer S Fusco, Karam C Mounzer, Gregory P Fusco

J Int AIDS Soc· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis